Nobiletin acts as a potential anticancer agent against osteosarcoma by regulating ERK and AKT signaling pathways. Bangladesh J Pharmacol [Internet]. 2014 Sep. 3 [cited 2026 Jul. 3];9(3):406-12. Available from: https://www.banglajol.info/index.php/BJP/article/view/19567